Colposcopy After an Abnormal Pap: What Happens Next

If your Pap or HPV test came back abnormal, your clinician likely used the word colposcopy next. That word can sound bigger than the appointment actually is. A colposcopy is an in-office exam, usually 10 to 20 minutes, where a clinician uses a lighted magnifying device called a colposcope to look closely at your cervix, the same view as a regular speculum exam, just magnified and lit. Most colposcopies find nothing that needs more than watching. When one does find something, that is the exam doing exactly what it is built to do: catching a change years before it could ever become cancer.

Pap and HPV results use specific language that sounds worse than it is. ASC-US (atypical squamous cells of undetermined significance) means a small number of cervical cells look mildly abnormal, almost always because of an HPV infection your immune system is still working through. LSIL (low-grade squamous intraepithelial lesion) is a step up: cells show clear low-grade changes, still usually caused by HPV that clears on its own within a year or two. HSIL (high-grade squamous intraepithelial lesion) means the changes are more advanced and more closely linked to precancer, which is why it is the result most likely to send you straight to colposcopy instead of a repeat test. None of these three results means you have cancer. They describe how closely your cervix needs to be watched next.

You lie back the same way you do for a Pap, feet in stirrups, while the clinician places a speculum to see the cervix. They apply a vinegar-like (acetic acid) solution with a cotton swab, which turns abnormal areas white so they stand out under the colposcope's light and magnification; this can cause a brief stinging or burning feeling. If an area looks abnormal, the clinician takes a small biopsy, a pinch of tissue about the size of a pencil eraser tip. The biopsy is the part that causes discomfort, usually described as a sharp cramp or pinch that passes within seconds. Taking an over-the-counter pain reliever an hour beforehand helps most women. Afterward, expect some spotting or dark discharge for a few days; skip tampons, sex, and douching until it clears, and ask your clinic what amount of bleeding should prompt a call.

Not every abnormal result leads to colposcopy right away. ASCCP, the professional society that writes the national management guidelines, bases the decision on your combined risk: your current result plus your screening history, not the current result by itself. In general, a positive high-risk HPV test paired with ASC-US or worse, or an HSIL result on its own, points to colposcopy. A single mild result in someone with a clean screening history more often means a repeat test in a year instead. If your clinician recommends colposcopy, it is because your specific combination of results crossed the risk threshold where a closer look changes what happens next, not because something is already wrong.

A biopsy result comes back as cervical intraepithelial neoplasia, or CIN, graded 1 to 3 by how much of the cervical tissue looks abnormal. CIN1 is a marker of active HPV, not precancer, and the standard approach is surveillance: repeat testing in a year rather than treatment, because most CIN1 clears on its own as the immune system handles the virus. CIN2 sits in between; younger women who want to preserve fertility are often offered continued monitoring for up to two years, while others move to treatment. CIN3 is the true precancer stage, and treatment is recommended for essentially everyone who receives that result. Treatment for CIN2 and CIN3 is usually a LEEP (loop electrosurgical excision procedure), a quick in-office procedure that removes the abnormal tissue with a thin heated wire loop, or, for more extensive disease, a cone biopsy done in an operating room. Both are outpatient. Removing the abnormal cells at this stage is what stops them from ever becoming cancer.

Biopsy results typically take 2 to 10 days to come back, depending on the lab. Ask before you leave the appointment how you will be notified (patient portal, phone call, or a scheduled follow-up visit), and write down the date you should expect to hear something. If more than two weeks pass with no word, call the office. A result that never reaches you is functionally the same as never having had the biopsy at all.

Colposcopy and the biopsy that comes with it are not optional extras bolted onto your Pap; both are diagnostic care, and there is a specific program built to pay for them. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP), funded by the CDC and run through state health departments, covers cervical cancer screening and the full diagnostic follow-up it can lead to, including colposcopy, for uninsured and underinsured women ages 21 to 64 with income at or below 250% of the federal poverty level. Every state runs a local version of this program, and it is not a loan or a promise: it is an eligibility category you either meet or don't, and participating clinics bill the program directly. Federally Qualified Health Centers, found in nearly every county, also offer colposcopy on a sliding fee scale regardless of insurance status. You can find free screening and follow-up near you through our screening directory, including local listings like this one for Tallahassee, Florida, or search your own city.

Cervical cancer is one of the most preventable cancers there is, precisely because it takes years to develop and gives screening and follow-up a wide window to catch it. Black women in the United States still die of this disease at a hysterectomy-corrected rate of 10.1 per 100,000, roughly double the corrected rate for white women, and the gap traces less to biology than to who completes the follow-up after an abnormal result. That means the colposcopy on your calendar, and whatever comes after it, is not a formality. It is the step that closes the gap for you specifically. Keep the appointment, ask for the result if it doesn't arrive on schedule, and if a biopsy calls for treatment, schedule that too.